Lifemd Inc Stock Performance
| LFMD Stock | USD 6.54 0.05 0.76% |
On a scale of 0 to 100, LifeMD holds a performance score of 8. The company secures a Beta (Market Risk) of 3.58, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, LifeMD will likely underperform. Please check LifeMD's standard deviation, value at risk, kurtosis, as well as the relationship between the sortino ratio and semi variance , to make a quick decision on whether LifeMD's current price movements will revert.
Risk-Adjusted Performance
8 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in LifeMD Inc are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, LifeMD exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.76) | Five Day Return 1.71 | Year To Date Return (22.42) | Ten Year Return 834.29 | All Time Return 3.2 K |
Last Split Factor 1:5 | Dividend Date 2020-10-14 | Last Split Date 2020-10-14 |
1 | Acquisition by Stefan Galluppi of 3000 shares of LifeMD at 4.93 subject to Rule 16b-3 | 09/11/2024 |
2 | Disposition of 200000 shares by Marc Benathen of LifeMD at 21.2 subject to Rule 16b-3 | 09/18/2024 |
3 | Analysts Set LifeMD, Inc. Target Price at 12.00 | 09/20/2024 |
4 | Cantor Fitzgerald Maintains LifeMD Overweight Recommendation - MSN | 09/25/2024 |
5 | LifeMD Inc Q2 2024 Earnings Call Highlights Strong Telehealth Growth and Strategic ... | 10/09/2024 |
6 | LifeMD Launches TestoRx, a New Rex MD Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering | 10/23/2024 |
7 | Earnings to Watch LifeMD Inc Reports Q3 2024 Result | 11/06/2024 |
8 | LifeMD Inc Q3 2024 Earnings Call Highlights Strong Telehealth Growth and Strategic ... | 11/08/2024 |
9 | LifeMD to Present at Three Major Healthcare Investor Conferences in November LFMD Stock News - StockTitan | 11/12/2024 |
10 | Acquisition by Nicholas Alvarez of 75000 shares of LifeMD subject to Rule 16b-3 | 11/29/2024 |
| Begin Period Cash Flow | 4 M |
LifeMD |
LifeMD Relative Risk vs. Return Landscape
If you would invest 499.00 in LifeMD Inc on September 4, 2024 and sell it today you would earn a total of 155.00 from holding LifeMD Inc or generate 31.06% return on investment over 90 days. LifeMD Inc is currently generating 0.5777% in daily expected returns and assumes 5.6792% risk (volatility on return distribution) over the 90 days horizon. In different words, 50% of stocks are less volatile than LifeMD, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
LifeMD Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LifeMD's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LifeMD Inc, and traders can use it to determine the average amount a LifeMD's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1017
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LFMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.68 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.58 actual daily | 11 89% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average LifeMD is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LifeMD by adding it to a well-diversified portfolio.
LifeMD Fundamentals Growth
LifeMD Stock prices reflect investors' perceptions of the future prospects and financial health of LifeMD, and LifeMD fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LifeMD Stock performance.
| Return On Equity | -7.82 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.09) % | ||||
| Current Valuation | 270.82 M | ||||
| Shares Outstanding | 43.31 M | ||||
| Price To Book | 107.72 X | ||||
| Price To Sales | 1.47 X | ||||
| Revenue | 152.55 M | ||||
| Gross Profit | 100.37 M | ||||
| EBITDA | (8.21 M) | ||||
| Net Income | (20.6 M) | ||||
| Cash And Equivalents | 5.84 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 18.93 M | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | (0.18) X | ||||
| Cash Flow From Operations | 8.82 M | ||||
| Earnings Per Share | (0.64) X | ||||
| Market Capitalization | 283.26 M | ||||
| Total Asset | 58.48 M | ||||
| Retained Earnings | (214.27 M) | ||||
| Working Capital | 7.82 M | ||||
About LifeMD Performance
By analyzing LifeMD's fundamental ratios, stakeholders can gain valuable insights into LifeMD's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LifeMD has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LifeMD has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 53.30 | 50.63 | |
| Return On Tangible Assets | (0.47) | (0.50) | |
| Return On Capital Employed | (0.61) | (0.58) | |
| Return On Assets | (0.35) | (0.37) | |
| Return On Equity | (5.88) | (6.17) |
Things to note about LifeMD Inc performance evaluation
Checking the ongoing alerts about LifeMD for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LifeMD Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LifeMD Inc is way too risky over 90 days horizon | |
| LifeMD Inc appears to be risky and price may revert if volatility continues | |
| LifeMD Inc currently holds 18.93 M in liabilities with Debt to Equity (D/E) ratio of 0.46, which is about average as compared to similar companies. LifeMD Inc has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about LifeMD's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 152.55 M. Net Loss for the year was (20.6 M) with profit before overhead, payroll, taxes, and interest of 100.37 M. | |
| LifeMD Inc has a frail financial position based on the latest SEC disclosures | |
| About 16.0% of LifeMD outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Nicholas Alvarez of 75000 shares of LifeMD subject to Rule 16b-3 |
- Analyzing LifeMD's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LifeMD's stock is overvalued or undervalued compared to its peers.
- Examining LifeMD's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LifeMD's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LifeMD's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LifeMD's stock. These opinions can provide insight into LifeMD's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for LifeMD Stock analysis
When running LifeMD's price analysis, check to measure LifeMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LifeMD is operating at the current time. Most of LifeMD's value examination focuses on studying past and present price action to predict the probability of LifeMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LifeMD's price. Additionally, you may evaluate how the addition of LifeMD to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |